Treatment of NF1-Associated Optic Pathway/Hypothalamic Gliomas in Patients With Diencephalic Syndrome

J Pediatr Hematol Oncol. 2023 May 1;45(4):e543-e546. doi: 10.1097/MPH.0000000000002569. Epub 2022 Oct 20.

Abstract

Diencephalic syndrome is usually associated with tumors in the hypothalamic region, rarely occurring in patients with neurofibromatosis type 1 (NF1)-associated gliomas. We describe the clinical presentation and response to treatment in 3 patients with NF1 presenting with diencephalic syndrome as first symptom of optic pathway/hypothalamic glioma (OPHG). Because of the rarity of this constellation, knowledge about the clinical course and best treatment options for patients with NF1-associated OPHG and diencephalic syndrome is still limited. All 3 patients showed good response to treatment with normalization of body mass index and decrease in tumor volume within 6 months.

MeSH terms

  • Humans
  • Infant, Newborn
  • Infant, Newborn, Diseases*
  • Neurofibromatosis 1* / diagnosis
  • Optic Nerve Glioma* / complications
  • Optic Nerve Glioma* / therapy
  • Syndrome